Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study
Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 32, pp. 3231-3239
Open Access | Times Cited: 132

Showing 51-75 of 132 citing articles:

Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment
AnnaLynn M. Williams, Edwin van Wijngaarden, Christopher L. Seplaki, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2020) Vol. 61, Iss. 7, pp. 1627-1635
Open Access | Times Cited: 18
Cognitive change in breast cancer patients up to 2 years after diagnosis
Marie Lange, Sophie Lefèvre‐Arbogast, Isabelle Hardy‐Léger, et al.
JNCI Journal of the National Cancer Institute (2022) Vol. 115, Iss. 3, pp. 322-331
Open Access | Times Cited: 11
Remote, Computerised Cognitive Assessment for Breast Cancer- and Treatment-Related Cognitive Dysfunction: Psychometric Characteristics of the Cogsuite Neurocognitive Battery
James C. Root, Alexandra M. Gaynor, Anam Ahsan, et al.
Archives of Clinical Neuropsychology (2023) Vol. 38, Iss. 5, pp. 699-713
Closed Access | Times Cited: 6
Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer
Michelle C. Janelsins, Lianlian Lei, Colleen Netherby-Winslow, et al.
Journal of Neuroimmunology (2021) Vol. 362, pp. 577769-577769
Open Access | Times Cited: 15
Lack of cognitive impairment in long-term survivors of colorectal cancer
Janette Vardy, Gregory R. Pond, Lucette A. Cysique, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 7, pp. 6123-6133
Open Access | Times Cited: 9
Cognitive function is well preserved in a cohort of breast cancer survivors: Roles of cognitive reserve, resilience, and general health
Sanna Liesto, Reetta Sipilä, Marja Hietanen, et al.
The Breast (2022) Vol. 65, pp. 157-163
Open Access | Times Cited: 9
The Fast Cognitive Evaluation (FaCE): a screening tool to detect cognitive impairment in patients with cancer
Amel Baghdadli, Giovanni G. Arcuri, Clarence G. Green, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Assessing cancer-related cognitive function in the context of everyday life using ecological mobile cognitive testing: A protocol for a prospective quantitative study
Ashley M. Henneghan, Kathleen Van Dyk, Robert A. Ackerman, et al.
Digital Health (2023) Vol. 9
Open Access | Times Cited: 5
Cognitive Impairment in Patients With Breast Cancer: Understanding the Impact of Chemotherapy and Endocrine Therapy
Patricia A. Ganz, Kathleen Van Dyk
Journal of Clinical Oncology (2020) Vol. 38, Iss. 17, pp. 1871-1874
Open Access | Times Cited: 14
Aberrant static and dynamic functional connectivity of the executive control network in lung cancer patients after chemotherapy: a longitudinal fMRI study
Lanyue Hu, Huiyou Chen, Wen Su, et al.
Brain Imaging and Behavior (2020) Vol. 14, Iss. 3, pp. 927-940
Open Access | Times Cited: 13
Trajectories of cognitive symptoms and associated factors in cancer survivors after return to work: an 18-month longitudinal cohort study
Johanna K. Ehrenstein, Sander K. R. van Zon, Saskia F. A. Duijts, et al.
Journal of Cancer Survivorship (2022) Vol. 17, Iss. 2, pp. 290-299
Open Access | Times Cited: 8
The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6 months post-chemotherapy
Amber S. Kleckner, Ian R. Kleckner, Eva Culakova, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 9, pp. 7655-7663
Open Access | Times Cited: 8
Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer‐Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy
Yi Long Toh, Juliana Shariq Mujtaba, Sumit Bansal, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2019) Vol. 39, Iss. 5, pp. 553-563
Open Access | Times Cited: 12
Cancer-Related Cognitive Impairment Associated with APOE rs7412 and BDNF rs6265 in Breast Cancer Survivors
Chao‐Pin Hsiao, T. Goto, Diane Von Ah, et al.
Seminars in Oncology Nursing (2024) Vol. 40, Iss. 5, pp. 151721-151721
Open Access | Times Cited: 1
Changes in S100 Calcium Binding Protein β (S100β) and Cognitive Function from Pre- to Post-Chemotherapy Among Women with Breast Cancer
Aaron N Huynh, AnnaLynn M. Williams, Elizabeth Belcher, et al.
Brain Behavior & Immunity - Health (2024) Vol. 41, pp. 100860-100860
Open Access | Times Cited: 1
Breast cancer, placing drug interactions in the spotlight: is polypharmacy the cause of everything?
José Alberto Domínguez-Alonso, David Conde‐Estévez, David D. Bosch, et al.
Clinical & Translational Oncology (2020) Vol. 23, Iss. 1, pp. 65-73
Closed Access | Times Cited: 11
A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment
Janette Vardy, Gregory R. Pond, Melanie L. Bell, et al.
Journal of Cancer Survivorship (2022) Vol. 17, Iss. 6, pp. 1583-1595
Open Access | Times Cited: 7
Cognitive dysfunction in patients with nasopharyngeal carcinoma after induction chemotherapy
Jun Wang, Chen‐Lu Lian, Hua Zheng, et al.
Oral Oncology (2020) Vol. 111, pp. 104921-104921
Closed Access | Times Cited: 9
Cancer-Related Cognitive Impairment or “Chemobrain:” Emerging Assessments, Treatments, and Targets for Intervention
Dominique Chao, Andrew C. Hale, N. Lynn Henry, et al.
Current Physical Medicine and Rehabilitation Reports (2021) Vol. 9, Iss. 3, pp. 108-118
Closed Access | Times Cited: 9
Prospective Rates, Longitudinal Associations, and Factors Associated With Comorbid Insomnia Symptoms and Perceived Cognitive Impairment
Sheila N. Garland, Hans Ivers, Josée Savard
Frontiers in Neuroscience (2022) Vol. 15
Open Access | Times Cited: 6
The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients
Sheng Yu, Jingjing Zhao, Menglian Wang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Social Support, social ties, and cognitive function of women with breast cancer: findings from the Women’s Health Initiative (WHI) Life and Longevity After Cancer (LILAC) Study
Yesol Yang, Eric McLaughlin, Michelle J. Naughton, et al.
Supportive Care in Cancer (2022) Vol. 31, Iss. 1
Open Access | Times Cited: 6
Cognitive impairment experienced by Chinese breast cancer survivors
Dan Chen, Lynette Mackenzie, Syeda Zakia Hossain, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Changes in Attentional Function in Patients From Before Through 12 Months After Breast Cancer Surgery
Carmen Köhler, Chang Ming, Yu-Yin Allemann-Su, et al.
Journal of Pain and Symptom Management (2020) Vol. 59, Iss. 6, pp. 1172-1185
Open Access | Times Cited: 8
Evaluation of a new online cognitive assessment tool in breast cancer survivors with cognitive impairment: a prospective cohort study
Anne Bellens, Ella Roelant, Bernard Sabbe, et al.
Supportive Care in Cancer (2021) Vol. 30, Iss. 1, pp. 21-31
Closed Access | Times Cited: 8

Scroll to top